CM101 is an anti-pathogenic angiogenic polysaccharide derived from Group B Streptococcus. It inhibits inflammatory angiogenesis, accelerates wound healing in mouse models, and reduces scar formation post-spinal cord injury. Additionally, CM101 rapidly induces tumor neovascular inflammation, promotes inflammatory cell infiltration, suppresses tumor growth, and induces tumor apoptosis (apoptosis).